Cargando…
Genomic risk prediction of aromatase inhibitor‐related arthralgia in patients with breast cancer using a novel machine‐learning algorithm
Many breast cancer (BC) patients treated with aromatase inhibitors (AIs) develop aromatase inhibitor‐related arthralgia (AIA). Candidate gene studies to identify AIA risk are limited in scope. We evaluated the potential of a novel analytic algorithm (NAA) to predict AIA using germline single nucleot...
Autores principales: | Reinbolt, Raquel E., Sonis, Stephen, Timmers, Cynthia D., Fernández‐Martínez, Juan Luis, Cernea, Ana, de Andrés‐Galiana, Enrique J., Hashemi, Sepehr, Miller, Karin, Pilarski, Robert, Lustberg, Maryam B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773952/ https://www.ncbi.nlm.nih.gov/pubmed/29168353 http://dx.doi.org/10.1002/cam4.1256 |
Ejemplares similares
-
Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias
por: Schnell, Patrick M, et al.
Publicado: (2021) -
Management of aromatase inhibitor–induced arthralgia
por: Younus, J., et al.
Publicado: (2010) -
Management of arthralgias associated with aromatase inhibitor therapy
por: Thorne, C.
Publicado: (2007) -
Randomized Controlled Trial of a Home‐Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor‐Associated Arthralgia in Breast Cancer Survivors
por: Nyrop, Kirsten A., et al.
Publicado: (2017) -
Patient satisfaction with information on oral anticancer agent use
por: Boons, Christel C. L. M., et al.
Publicado: (2017)